Issue 79, 2022

COF-based nanoreactors for click-activated prodrug delivery and precise anti-vascular therapy

Abstract

Herein, we report a new click-activated prodrug, CA4V, and a bioorthogonal nanoreactor, CA4V/ZIF-90@TzCOF@Apt, which consists of a ZIF-90 core, tetrazine-based covalent organic framework (COF) shells and an aptamer polymer coating. When targeting a tumor, the acid-causing collapse of ZIF-90 initiates a nanoconfined bioorthogonal reaction in defined COF cages, which boosts the click efficiency of CA4V activation and therapeutic effects in vivo.

Graphical abstract: COF-based nanoreactors for click-activated prodrug delivery and precise anti-vascular therapy

Supplementary files

Article information

Article type
Communication
Submitted
14 Jul 2022
Accepted
01 Sep 2022
First published
02 Sep 2022

Chem. Commun., 2022,58, 11107-11110

COF-based nanoreactors for click-activated prodrug delivery and precise anti-vascular therapy

P. Wang, M. Li, F. Zhou, Y. Yang, X. Yin, X. Zhang and G. Song, Chem. Commun., 2022, 58, 11107 DOI: 10.1039/D2CC03931A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements